Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2003
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096267 Essential bacterial genes and their use
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096241 Method of testing squamous epithelial cells
05/22/2003US20030096027 Alpha acid, (e.g., humulone) or beta acid (e.g., lupulone)
05/22/2003US20030096019 Methods of using norfluoxetine
05/22/2003US20030096016 Methods of kidney transplantation utilizing developing nephric tissue
05/22/2003US20030096008 Tetracycline - Doxycycline antibiotic composition
05/22/2003US20030096007 Amoxicillin-dicloxacillin antibiotic composition
05/22/2003US20030096006 Three dosage forms with different release profiles
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003US20030095988 Using an optimum dose of the pathogen itself as an antigen to increase pathogen-specific immune responses; especially effective when the treatment phase is followed by an interruption phase ending upon relapse
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095959 Topical skin composition
05/22/2003US20030095955 Provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
05/22/2003US20030095953 Methods of reversing drug resistance in cancer cells
05/22/2003US20030095932 Oxidative fluorinator compounds as antimicrobials
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003CA2467068A1 C-5 modified indazolylpyrrolotriazines
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466659A1 Anticancer agents
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466465A1 Nk1 antagonists
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2466355A1 Neurotransmitter balance chemotherapy
05/22/2003CA2466344A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003CA2466264A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof
05/22/2003CA2466118A1 Modulation of lir function to treat rheumatoid arthritis
05/22/2003CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003CA2465334A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2460027A1 Medical devices having antimicrobial coatings thereon
05/21/2003EP1312920A1 Method of screening remedy for heart failure
05/21/2003EP1312379A1 Fibrinogen lowering agents
05/21/2003EP1312365A1 Pteridinones for the treatment of erectile dysfunctions
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1312362A1 Method for the suppression of visceral pain by regulating T-type calcium channel
05/21/2003EP1312359A2 Use for 1,3-propanediol compounds
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311708A1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311691A2 Method and compositions for promoting osteogenesis
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311667A2 Transgenic animal model for neurodegerative disease and uses thereof
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311660A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4
05/21/2003EP1311656A1 Use of bioactive glass compositions to stimulate osteoblast production
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311531A1 Steroid derived antibiotics
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311299A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
05/21/2003EP1311294A2 Formulations of mometasone and a bronchodilator for pulmonary administration
05/21/2003EP1311293A2 Combinations of ssri and estrogenic agents
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1311274A1 New use
05/21/2003EP1311273A2 Combination of a purine and an nsaid for treating sexual dysfunction
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311266A2 Combination hiv therapy including camptothecin
05/21/2003EP1311262A1 Cancer treatment by combination therapy
05/21/2003EP1311260A2 Lipase inhibitors to treat dyspepsia
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311253A2 Use of vitamin d derivatives as bone resorption inhibitors
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1311251A2 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
05/21/2003EP1311245A1 Hybrid neuroprosthesis for the treatment of brain disorders
05/21/2003EP1311244A2 Steroid hormones as transfer agents
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1039802B1 Transdermal therapeutic device with capsaicin and capsaicin analogs
05/21/2003EP1017367B1 Methods for fabricating polymer-based controlled release preparations
05/21/2003EP0988042A4 A combination therapy for hiv infections
05/21/2003EP0918528B1 Use of hyperimmunized milk and/or egg for treating gastrointestinal damage
05/21/2003EP0876613B1 Treatment and diagnosis of infections due to helicobacter pylori
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0817625B1 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
05/21/2003EP0797442B1 Treatment of optic neuritis
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1419447A Diphenyl ketoaldehyde derivatives with anti-HIV activity
1 ... 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 ... 1151